Newsflash

LIFT Cancer Trial Starting in China
A new clinical trial based on Dr. Zheng Cui's granulocyte technology is starting at Beijing's 304 Hospital. Go to The LIFT Cancer Treatment Trial Site for more information.
Welcome to Cancer Therapy China
Welcome To Cancer Therapy China PDF Print E-mail
Written by Administrator   
Thursday, 30 July 2009 12:39

At Cancer Therapy China (sponsored by China Cancer Centers Ltd.), we are dedicated to providing cancer patients and their families with information about the newest and most promising cancer treatments currently available in the world. Using our labs and technology, we pair patients with the best hospitals in China to receive treatments for their particular cancer.

 

 


China has quickly become a place of cancer expertise as many of its hospitals and research facilities open up to the world to share their industry-leading research. Numerous treatments offered in China have not found their way over to many Western countries that still use traditional methods of combating cancer through surgery, chemotherapy, and radiotherapy. While sometimes effective, we realize that these treatments have powerful side effects that make dealing with cancer much more difficult and painful. Treatments we provide that are not available everywhere in the world include gene therapy (Gendicine), immunotherapy (CIK or DC-CIK biotherapy), anti-angiogenesis drug therapy (Endostar), gentle chemotherapy, HIFU non-invasive surgery, cryoablation minimal invasive surgery, cancer stem cell targeted treatment, Gamma knife and traditional Chinese medicine (herb). These have all shown promising results as well as very little detrimental side effects.

 

With doctors fluent in English and top-quality treatment; our cancer treatment centers gladly welcome patients from around the world.

Click here to learn more about our treatments and therapies.

Last Updated on Thursday, 26 August 2010 09:26
 
2009 Nobel Laureates' Discovery -- A New Therapeutic Strategy for cancer PDF Print E-mail
Written by Administrator   
Saturday, 10 October 2009 14:07

This year’s Nobel Prize in Physiology or Medicine is awarded to three scientists who have solved a major problem in biology: how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes — the telomeres — and in an enzyme that forms them — telomerase.

 

Last Updated on Thursday, 26 August 2010 09:28
Read more...
 
CCC Research Brings Big Steps For CIK Therapy PDF Print E-mail
Written by Administrator   
Monday, 30 March 2009 10:30

In the coming weeks, CCC researchers plan to publicly announce the cutting-edge progress they have made in the application of CIK therapy. In recent research, CIK cells cultured from umbilical cord blood were used in animal trials. In these trials, the new CIK cells effectively killed the cancer cells 80% of the time.

 

There is still more testing to be done, as animals are quite different than complex human bodies. However, umbilical cord CIK cells are showing great promise in the near future for human application. Dosage can greatly affect effectiveness, and researchers are currently testing variables regarding dosage, time, and interval of injection. Thus far, CCC researchers have successfully used CIK to kill 9 types of cancer:

Last Updated on Monday, 19 July 2010 10:18
Read more...
 
Back On His Feet- A Success Story PDF Print E-mail
Written by Administrator   
Monday, 27 April 2009 10:03

Nicholas, a 32 year old lawyer, husband, and father from Romania, was admitted to our centers on April 2, 2009. Nicholas and his wife Madalina have experienced tremendous ups and downs in their search for treatment for Nicholas’ cancer. He has Hodgkin’s disease (a lymphatic type of cancer) and was recently additional diagnosed with progressive multifocal leukoencephalopathy (PML).

 

Last Updated on Tuesday, 20 July 2010 16:14
Read more...
 
CIK-DC: A New Antigen Bank PDF Print E-mail
Written by Administrator   
Tuesday, 21 April 2009 10:31

 

In June 2009, CCC unveiled it’s newest therapy: CIK-DC (cytokine-induced killer cells combined with dendritic cells). On its own, CIK is still an excellent tool against cancer: it fights and kills cancer cells systemically, boosts and restores the body’s own immune system (especially after the harsh, depleting effects of chemotherapy), and prevents metastasis and recurrence. What do DC cells do? DC cells give CIK a boost that allows CIK cells to more effectively target the location of cancer cells. Cultured from umbilical cord blood, the DC cells are especially potent at assisting CIK cells to protect the body while killing cancer cells. 

 

Last Updated on Wednesday, 25 August 2010 18:21
Read more...